Reasons to Retain EYE Stock in Your Portfolio for Now

Zacks2024-12-04

National Vision Holdings, Inc.’s EYE growth in the third quarter is backed by the consistent market expansion of the Owned and Host segment. The company’s strategic progress in terms of expanding exam...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2488194910?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea","is_english":true,"pubTime":"2024-12-04 20:47","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2488194910","market":"us","top_or_hot":-1,"title":"Reasons to Retain EYE Stock in Your Portfolio for Now","media":"Zacks","content":"<div>\n<p>National Vision Holdings, Inc.’s EYE growth in the third quarter is backed by the consistent market expansion of the Owned and Host segment. The company’s strategic progress in terms of expanding exam...</p>\n\n<a href=\"https://finance.yahoo.com/news/reasons-retain-eye-stock-portfolio-124700852.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reasons to Retain EYE Stock in Your Portfolio for Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReasons to Retain EYE Stock in Your Portfolio for Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-04 20:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/reasons-retain-eye-stock-portfolio-124700852.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>National Vision Holdings, Inc.’s EYE growth in the third quarter is backed by the consistent market expansion of the Owned and Host segment. The company’s strategic progress in terms of expanding exam...</p>\n\n<a href=\"https://finance.yahoo.com/news/reasons-retain-eye-stock-portfolio-124700852.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GMED","symbol_name":"Globus Medical Inc","start_time":0,"source_url":"https://finance.yahoo.com/news/reasons-retain-eye-stock-portfolio-124700852.html","article_id":"2488194910","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_9OKqED6rOANF8VtUei37A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488194910","pubTimestamp":1733316420,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"National Vision Holdings, Inc.’s EYE growth in the third quarter is backed by the consistent market expansion of the Owned and Host segment. The company’s strategic progress in terms of expanding exam capacity, recruitment and retention efforts and remote exam initiatives is highly encouraging. However, mounting expenses due to slow economic conditions, along with fierce competitive pressure, add to the worry.In the past year, this Zacks Rank #3  company’s shares have lost 39.1% against the industry’s 21.3% growth and the S&P 500 composite’s 32.7% increase.The leading optical retailer has a market capitalization of $909.6 million. National Vision beat on earnings in each of the trailing four quarters, delivering an average surprise of 93.73%.Future Strategies Look Promising: National Vision is advancing its transformation efforts with new additions to the leadership team, continued expansion of exam capacity, new traffic-driving initiatives and actions to strengthen its business founda","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"GMED":"Globus Medical Inc","LU0566484027.USD":"安本美国小盘成长股","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","BK4082":"医疗保健设备","PEN":"Penumbra Inc","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","EYE":"National Vision","BK4198":"医疗保健用品","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","IE0009354923.USD":"JANUS HENDERSON US VENTURE \"A2\" (USD) ACC","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","BK4200":"专卖店","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","BK4548":"巴美列捷福持仓","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","HAE":"美国血液技术","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC"},"translate_title":"目前在您的投资组合中保留EYE股票的理由","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEN":1,"EYE":1,"HAE":1,"GMED":0.9},"content_text":"National Vision Holdings, Inc.’s EYE growth in the third quarter is backed by the consistent market expansion of the Owned and Host segment. The company’s strategic progress in terms of expanding exam capacity, recruitment and retention efforts and remote exam initiatives is highly encouraging. However, mounting expenses due to slow economic conditions, along with fierce competitive pressure, add to the worry.\nIn the past year, this Zacks Rank #3 (Hold) company’s shares have lost 39.1% against the industry’s 21.3% growth and the S&P 500 composite’s 32.7% increase.\nThe leading optical retailer has a market capitalization of $909.6 million. National Vision beat on earnings in each of the trailing four quarters, delivering an average surprise of 93.73%.\nLet’s delve deeper.\nKey Upsides of EYE\nOwned & Host Gaining Market Share: All four sub-segments within Owned and Host are consistently gaining market share, banking on several growth drivers. America's Best is particularly driving revenues banking on the ongoing strength in managed care. In the third quarter of 2024, America’s Best became the exclusive U.S. retail partner of the Florence by Mills eyewear collection and inked a special partnership with Pair Eyewear nationwide. \nNational Vision is deploying remote medicine technology in tandem with electronic health record technology to drive expanded capacity and improve in-store efficiency and patient experience. Remote exams currently represent about 11% of assessments in remote-enabled states. Additionally, the company expanded its hybrid remote pilot to 16 stores where optometrists remotely perform exams in other stores, based on availability and demand. \nFuture Strategies Look Promising: National Vision is advancing its transformation efforts with new additions to the leadership team, continued expansion of exam capacity, new traffic-driving initiatives and actions to strengthen its business foundation for profitable growth. \nThe company recently completed a comprehensive store fleet review to align its real estate investments with higher standards, optimize profitability for the long term and improve the overall health of the core business. The results of this review include a plan to close 39 stores through 2026 that is expected to deliver approximately $4 million in adjusted EBITDA improvement by the end of the year. In the fourth quarter of 2024, four Detroit-based Eyeglass World stores are set to be converted to America's Best.\nNational Vision is leveraging its omnichannel capabilities by testing and advancing programs that attract consumers across omnichannel offerings. Further, the company plans to allocate marketing expenditures more effectively for Eyeglass World to drive operational improvements.\nKey Downsides of EYE\nTough Competition: National Vision operates in a highly competitive optical retail industry. The companies within the industry generally compete based on recognition of the brand name, price, convenience, selection, service and product quality. National Vision competes with national retailers like LensCrafters, Pearle Vision and Visionworks in the broader optical retail industry. Competition exists in physical retail stores as well as e-commerce platforms. \nImage Source: Zacks Investment Research\nMounting Expenses: Over the past few years, global markets and economic conditions have been challenging, particularly in light of rising interest rates and historic inflation throughout 2023 and global conflict, which has created continued economic uncertainty. The company expects this trend to continue into 2024 and beyond. In the third quarter of 2024, SG&A expenditures were 51.8% of the total revenues and rose 2.8% year over year. \nEstimate Trend\nThe Zacks Consensus Estimate for 2024 earnings per share (EPS) has moved north 6.5% to 49 cents in the past 30 days.\nThe Zacks Consensus Estimate for 2024 revenues is pegged at $1.84 billion, implying a 13.3% decline from the year-ago reported number.\nKey Picks\nSome better-ranked stocks in the broader medical space are Haemonetics HAE, Globus Medical GMED and Penumbra PEN.\nHaemonetics has an earnings yield of 5.02% compared with the industry’s 1.18%. Its earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 19.39%. Its shares have risen 3.6% compared with the industry’s 19.9% growth in the past year.\nHAE carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.\nPenumbra, carrying a Zacks Rank #2 at present, has an estimated 2024 earnings growth rate of 33.5% compared with the industry’s 15.9%. Shares of Penumbra have risen 3.2% compared with the industry’s 14.5% growth over the past year. PEN’s earnings surpassed estimates in three of the trailing four quarters and missed in one, the average surprise being 10.54%.\nGlobus Medical, carrying a Zacks Rank #3 at present, has a long-term estimated growth rate of 14.1%. Shares of the company have rallied 81.8% compared with the industry’s 14.5% growth. GMED’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 17.65%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nHaemonetics Corporation (HAE) : Free Stock Analysis Report\nGlobus Medical, Inc. (GMED) : Free Stock Analysis Report\nPenumbra, Inc. (PEN) : Free Stock Analysis Report\nNational Vision Holdings, Inc. (EYE) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488194910"}